Prior to coronavirus disease 2019 (COVID-19), tuberculosis (TB) was the worst killer among
infectious diseases. The union of these two obnoxious respiratory diseases can be …

Abstract Treatment of tuberculosis (TB) involves the administration of anti-mycobacterial
drugs for several months. The emergence of drug-resistant strains of Mycobacterium …

Background Tuberculosis is usually treated with a 6-month rifampin-based regimen.
Whether a strategy involving shorter initial treatment may lead to similar outcomes is …

Airway disease is a major healthcare issue that causes at least 3 million fatalities every year.
It is also considered one of the foremost causes of death all around the globe by 2030 …

China has made remarkable progress in reducing tuberculosis cases and deaths during the
past three decades; however, it is still far from achieving the targets set out in the WHO End …

Vaccination is one of medicine's greatest achievements; however, its full potential is
hampered by considerable variation in efficacy across populations and geographical …

The clinical use of antibiotics has led to the emergence of multidrug-resistant (MDR)
bacteria, leading to the current antibiotic resistance crisis. To address this issue, next …

The antimicrobial resistance crisis requires the introduction of novel antibiotics. The use of
conventional broad-spectrum compounds selects for resistance in off-target pathogens and …

Mycobacterium tuberculosis is one of the global leading causes of death due to a single
infectious agent. Pretomanid and delamanid are new antitubercular agents that have …

Induction of lipid-laden foamy macrophages is a cellular hallmark of tuberculosis (TB)
disease, which involves the transformation of infected phagolysosomes from a site of killing …